Acabrunat (Acalabrutinib)

Acabrunat, also known as Acalabrutinib, is an oral medication primarily used in the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). This targeted therapy works by inhibiting Bruton's tyrosine kinase (BTK), a critical enzyme involved in the survival and proliferation of malignant B-cells.

One of the significant advantages of Acabrunat is its ability to selectively target cancer cells while minimizing effects on normal cells. This selectivity often results in fewer side effects compared to traditional chemotherapy options. Patients may experience side effects such as headache, diarrhea, and fatigue, but these are generally manageable.

Acabrunat is typically administered twice daily, with or without food, making it a convenient option for many patients. Regular monitoring by healthcare professionals is essential to assess the treatment's effectiveness and manage any potential side effects.

Clinical studies have demonstrated that Acabrunat can lead to improved progression-free survival rates in patients with CLL and SLL. Its efficacy, combined with a favorable safety profile, makes it a vital option in the evolving landscape of hematologic malignancies.

As with any medication, it is crucial for patients to discuss their individual health conditions and treatment goals with their healthcare provider to determine if Acabrunat is the right choice for their cancer treatment.

• Acalabrutinib


• Inactive ingredients


• Microcrystalline cellulose


• Magnesium stearate


• Hydroxypropyl methylcellulose


• Iron oxide red


• Iron oxide yellow

Before starting Acabrunat (Acalabrutinib), it is important to consult your healthcare provider to ensure it is appropriate for your condition. Follow the instructions provided by your doctor regarding dosage and administration.

Acabrunat is typically taken orally, with or without food. It is essential to take the medication at the same time each day to maintain consistent levels in your body. Here are the steps to follow when using Acabrunat:

1. Preparation: Gather your medication and any necessary supplies, such as a glass of water.


2. Dosage: Take the prescribed dose as directed by your healthcare provider. Do not take more or less than recommended.


3. Administration: Swallow the capsule whole with a glass of water. Do not open, crush, or chew the capsule, as this can affect the medication's effectiveness.


4. Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.


5. Regular Monitoring: Attend all scheduled appointments with your healthcare provider for monitoring and assessment of your response to the treatment.

While using Acabrunat, inform your healthcare provider about any side effects you may experience, such as headache, diarrhea, or fatigue. It is also essential to discuss any other medications you are taking to avoid potential interactions.

In case of an overdose, seek emergency medical attention immediately. Symptoms of overdose may include severe dizziness, fainting, or unusual bleeding. Always keep the medication out of reach of children and store it at room temperature, away from moisture and heat.

Remember, your healthcare provider is your best resource for any questions or concerns regarding Acabrunat and your treatment plan.